Medical Biochemistry
Glycolysis/TCA/ETS
Robert F. Waters, PhD
Glycolysis(Introduction)Glucose + 2 ADP + 2 NAD+ + 2 Pi -----> 2 Pyruvate + 2 ATP + 2 NADH + 2 H+
Cofactors needed Mg++ for ATP
Ca++, Zn++, Cd++ for absorption of glucose
Glycolysis
Anaerobic (Hypoxia) Aerobic (Inhibits Glycolysis)
Tries to make pyruvate Cytosol Glucose Absorption and Transport
Glucose General Information Glucose turnover of 70kg (154 lb) person
~2mg/kg/min or 200g/24hrs.
Hypoglycemic substances Insulin
Binds on cells to IRS-1 (Insulin receptor substrate) Stimulates TG synthesis Blocks Lipolysis (Increases LDLs)
Hyperglycemic substances Glucagon, epinephrine, HGH, cortisol
Stimulatory Substances for Insulin Production GIP-glucose dependent insulinotropic peptide CCK-cholecystokinin (pancreozymin) GLP-1 glucagon like peptide VIP-vasoactive intestinal peptide
NOTE: This is the reason the body has a better insulin response orally rather than IV.
Digestion Cont:
Glucose Absorption Glucose Transporters (GLUTs)
Glut-1 = erythrocytes Glut-2 = liver and pancreas Glut-3 = brain Glut-4 = skeletal muscle and adipose tissue Glut-5 = small intestine (Fructose Transport)
Cotransported with Na+ Na+ dependent glucose transport
Active Transport Most monosaccharides can cross brush border but extremely slow
(diffusion) Fructose is absorbed by Na+ independent facilitated transport (ATP
consumed as well)
Glycolysis Glucose to Glucose-6-phosphate
Hexokinaseglucose-6-phosphate (G6P)is the first reaction of glycolysis,
and is catalyzed by tissue-specific isoenzymes known as hexokinases
Glucokinase• Four mammalian isozymes of hexokinase are known (Types I - IV),
with the Type IV isozyme often referred to as glucokinase. Glucokinase is the form of the enzyme found in hepatocytes. The high Km of glucokinase for glucose means that this enzyme is saturated only at very high concentrations of substrate.
Glycolysis
The Km for hexokinase is significantly lower (0.1mM) than that of
glucokinase (10mM).
Glycolysis
G-6-P inhibits hexokinase Glucose stimulates hexokinase production Concept of Km? Definition of a Kinase Mg++ or Mn++ Inhibited by Fluorine
Glycolysis
Glucose-6-Phosphate to Fructose-6-Phosphate Isomerase
-D-Fructose-6-phosphate
Glycolysis Fructose-6-phosphate to Fructose-1,6-
bisphosphatePFK-1PFK-2 Insulin to Glucagon ratioCitrate InhibitsATP inhibitsMn++ or Mg++ Inhibited by fluorine
-D-Fructose-1,6-bisphosphate
Glycolysis
Split of F-1,6-bisphosphate into dihydroxyacetone phosphate and phosphoglyceraldehyde (DHAP and PGAL)
Triose phosphate isomerase Aldolase A (Isoenzyme) isomerase
Glycolysis
PGAL to 1,3 bisphosphoglycerate Substrate level Phosphorylation Inhibited by Arsenate Add Pi
Glycolysis
Erythrocytes1,3-bisphosphoglycerate to 2,3-bisphosphoglycerate to
3-phosphoglycerateMutasephosphatase
All cells metabolizing1,3-bisphosphoglycerate to 3-phosphoglyceratephosphoglycerokinase
Glycolysis
3-phosphoglycerate to 2-phosphoglyceratePhosphoglyceromutase
Glycolysis
2-phosphoglycerate to phosphoenolpyruvateEnolase Inhibited by fluorine (halogens)
Glycolysis
PEP to PyruvatePyruvate kinase
Glycolysis
Anaerobic conditionsPyruvate to lactate
Lactate dehydrogenase
Aerobic conditionsPyruvate to mitochondrial TCA cycle
Pyruvate-keto acid form of alanine
Glycolytic Control Mechanisms
Hexokinase Insulin StimulatesGlucose Stimulates Inhibited by G-6-P
G-6-P does not inhibit glucokinase
Inhibited by Glucagon
Glycolytic Control—PFK-1
Stimulated by AMP Stimulated by Fructose 2,6-bisphosphate Inhibited by ATP Inhibited by Citrate Inhibited by Glucagon
Glycolysis Control Mechanisms
PFK-1 and PFK-2
Insulin to Glucagon Ratio
Glycolytic Control-Pyruvate Kinase
Stimulated by Fructose 1,6-bisphosphate Inhibited by Glucagon
Glycolytic Metabolic Lesions Hexokinase Deficiency
Hemolytic Anemia Lactic Acidosis
Normal Blood Levels-1.2 mM High Levels 5 mM or more May be due to high lactate production or utilization
Hypoxia Reduces Mitochondrial ATP Production Activates PFK-1 Stimulates Glycolysis Increased Lactate Production May be caused [hypoxia] by reduced blood flow in tissue (shock), respiratory disorders, etc.
Pyruvate Kinase Deficiency
Pyruvate Kinase exists as isoenzymes One or more subunits may be affected Ionic imbalance causing erythrocytes to swell Hemolytic anemia-excessive RBC destruction
Pyruvate Kinase Deficiency-Cont. Presentation
Newborn anemic and jaunticed Hematology
Variability in cell morphology Above normal reticulocytes/total RBC ratio
Pyruvate Kinase activity is ~20% of normal Treatment
None for the most part Splenectomy under high anemic conditions Probably splenomegaly and hepatomegaly
The Mitochondria
mtDNA mtRNA Inorganic Phosphate Carrier Molecule ATP Transport Molecules
Pyruvate Dehydrogenase Complex
Decarboxylation Vitamins and pseudo-vitamins
Niacin, Riboflavin, -lipoic acid, Thiamine, CoA (Pantothenate)
Enzyme Complex (E1,E2,E3)Pyruvate Decarboxylase (CO2) 3C to 2C,
dihydrolipoyltransacetylase, dihydrolipoyldehydrogenase
PDH Regulation
Inhibited by;Acetyl CoANADH
Stimulated by;CoASHNAD+Pyruvate
PDH Stimulation Through Inhibition For example NAD+ inhibits Protein Kinase which does
NOT phosphorylate PDH enzymes and keeps them active. ATP and Mg++ are necessary for Protein Kinase Phosphoprotein Phosphatase removes phosphates from
phosphorylated enzymes. This enzyme is stimulated by Ca++
NOTE: [Ca] concentration and [ATP] concentration in mitochondria are inversely related.
Further PDH Regulation
Insulin Stimulates PDH in Adipose Tissue Catecholamines in cardiac muscle stimulates PDH
DopamineNorepinephrineepinephrine
Example of Cortisol Activating PDH in Cardiac Muscle Adrenal Cortex Secretes Cortisol
A glucocorticoid (Also anti-inflammatory)
Cortisol moves into adrenal medulla Stimulates Phenylethanolamine N-methyltransferase
Converts norepinephrine to epinephrine
Epinephrine secreted into blood and activates PDH complex Genetic inhibition by epinephrine
Epinephrine Production
Defects in PDH Complex
Severe cases are fatal Symptoms
Lactic AcidosisNeurological DisordersHigh Serum [Pyruvate]High Serum [Alanine]
PDH Defect Treatments
Large doses of thiaminHelps with E1 defect
Large doses of lipoic acidHelps with E2 defect
Ketogenic Diet rather than GlucogenicKetogenic Amino Acids
Isoleucine, leucine, tryptophan, lysine, phenylalanine, tyrosine
TCA Cycle
Tricarboxylic Acid Cycle Krebs Cycle Citric Acid Cycle Mitochondrial Matrix
TCA Cycle
OxaloacetateKeto Acid form of AspartateRegenerating Substrate (4-carbons)
Acetyl-CoAStoichiometric Substrate (2-carbons)
Citrate Synthase (Irreversible)Produce Citrate (6-carbons)
TCA Cycle Citrate to Isocitrate
Citrate less water cis-Aconitate Cis-Aconitate plus water isocitrate Prochiral carbon
Carbon with three different groups therefore distinguish between which COO- and stereospecificity with enzyme
Cis-aconitase Bidirectional (isoergonic)
Reactants to products favored (exergonic) Products to reactants favored (endergonic)
TCA Cycle
Isocitrate to -ketoglutarate Isocitrate dehydrogenase
Regulatory enzymeNADHCO2
Oxidative decarboxylationCoupled with reduced NAD and oxidative phosphorylation
TCA Cycle
-ketoglutarate to Succinyl-CoA -ketoglutarate dehydrogenase
Niacin, Riboflavin, Thiamine, -lipoic acidMulti-subunit enzyme structure
CO2Keto acid form of Glutamate
TCA Cycle
Succinyl CoA to SuccinateSuccinate thiokinase (kinase)Coupled Reaction
GDP + Pi GTPADP ATPSubstrate level Phosphorylation NOT Oxidative
Phosphorylation in the production of ATP
TCA Cycle
Succinate to FumarateSuccinate Dehydrogenase
Oxidation of succinate to fumarateReduction of FAD+ to FADH
TCA Cycle
Fumarate to MalateFumarase
Hydration of fumarate to malateisoergonic
TCA Cycle
Malate to OxaloacetateMalate dehydrogenase
Reduced NAD (NADH)IsoergonicSlighty endergonic (Slightly favors malate formation)
ATP Production
8 ATP - Glycolysis 30 ATP - PDH and TCA Cycle Theoretical Number of ATP (38) Actual ~36 ATP per mole of glucose
TCA Cycle Control
Citrate Synthase (Synthetase)Condensing Enzyme Inhibited By:
ATPNADHSuccinyl CoA
TCA Cycle Control-Cont:
Isocitrate DehydrogenaseActivated By:
ADP
Inhibited By:ATPNADH
TCA Cycle Control-Cont:
-Ketoglutarate Dehydrogenase Inhibited by:
Succinyl CoANADHATP
Contains tightly bound Tpp, lipoamide, FADSimilar to PDH complex
E3 subunit the same
TCA Cycle Control-Cont:
Succinyl CoA SynthetaseCoupled reaction with GTPEnzyme that catalyses coupled reaction is called
Nucleotidediphosphate Kinase
TCA Cycle Control-Cont:
Succinate DehydrogenaseHas Iron-Sulfur CentersCovalently Bound with FAD
General TCA Information Amphibolic
Involved in catabolic and anabolic processes Anaplerotic Reactions
Increase concentrations of TCA cycle intermediates Example: Amino Acid Metabolism
Aminotransferase: Glutamate and -ketoglutarate Aminotransferase: Aspartate and Oxaloacetate Pyruvate Carboxylase: Gluconeogenesis
Pyruvate + CO2 Oxaloacetate
The aminotransferase associated with alanine and pyruvate is not anaplerotic because pyruvate is not TCA intermediate.
Specifics of Pyruvate Dehydrogenase Complex E1
Pyruvate Decarboxylase Liberates CO2
Thiamine (TPP) E2
Dihydrolipoyltransacetylase Produces Acetyl-CoA -lipoic Acid CoA-Pantothenic Acid
E3 Dihydrolipoyldehydrogenase
Produces FADH to NADH Riboflavin and Niacin
Malate Aspartate Shuttle
Glycerophosphate Shuttle
Cytochromes
Cytochrome c oxidase contains two haem a groups, one binuclear copper site (CuA), one mononuclear copper site (CuB) and one bound Mg2+ per
monomer plus FeII and FeIII iron associated with sulfur (S).
Cytochrome c Oxidase (COX)
Do NOT get confused with cyclooxygenase also called COX!
Cytochrome c Oxidase Cycle
Co-enzyme Qx
1. Impaired coenzyme Q10 synthesis due to nutritional deficiencies. (Ubiquinone)
2. Genetic or acquired defect in coenzyme Q10 synthesis.
3. Increased tissue needs resulting from a particular medical condition.
Co-enzyme Q10
Interconversion Isoprenoid Units
Electron Transport System
Oxidative Phosphorylation
Electron Transport Continued;
Enzyme Information
kDa
Complex INADH dehydrogenase (or)NADH-coenzyme Q reductase
800 25
Complex IISuccinate dehydrogenase (or)Succinate-coenzyme Q reductase
140 4
Complex III Cytochrome C - coenzyme Q oxidoreductase 250 9-10
Complex IV Cytochrome oxidase (Copper) 170 13
Complex V ATP synthase 380 12-14
Electron Transport Continued;
Complex I
NADH + H+
FMN
Fe2+S
CoQ
NAD+ FMNH2 Fe3+S CoQH2
Electron Transport Continued;
Complex II
Succinate
FAD
Fe2+S
CoQ
Fumarate FADH2 Fe3+S CoQH2
Electron Transport Continued;
Complex III
CoQH2
cyt b ox
Fe2+S
cyt c1 ox
cyt c red
CoQ cyt b red Fe3+S cyt c1 red cyt c ox
Electron Transport Continued;
Complex IV
cyt c red
cyt a ox
cyt a3 red
O2
cyt c ox cyt a red cyt a3 ox 2 H2O
Electron Transport Continued;
Chemistry of Complex V
ETS-Cont:
kDa
Complex INADH dehydrogenase (or)NADH-coenzyme Q reductase
800 25
Complex IISuccinate dehydrogenase (or)Succinate-coenzyme Q reductase
140 4
Complex III Cytochrome C - coenzyme Q oxidoreductase 250 9-10
Complex IV Cytochrome oxidase (Copper) 170 13
Complex V ATP synthase 380 12-14
Electron Transport Inhibitors
Complex IMany insecticidesBarbiturates
AmobarbitalSecobarbital
Some antibiotics
Electron Transport Inhibitors-Cont:
Complex IIISome antibiotics
Complex IVH2S
CyanideAzideCO
Electron Transport Inhibitors-Cont: Cyanide Poisoning (Example)
Almond smell of gaseous CN (breath)Severe Acidosis
A cancer treatment in Mexico is called Amygdalin (extracted from almonds) may be harmful due to CN is metabolite.
TreatmentInfusion of thiosulfate (binds CN)Ventilation with 100% O2
Administer Sodium Bicarbonate